MA40781A - Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale - Google Patents
Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie oraleInfo
- Publication number
- MA40781A MA40781A MA040781A MA40781A MA40781A MA 40781 A MA40781 A MA 40781A MA 040781 A MA040781 A MA 040781A MA 40781 A MA40781 A MA 40781A MA 40781 A MA40781 A MA 40781A
- Authority
- MA
- Morocco
- Prior art keywords
- isotretinoin
- pharmaceutical composition
- oral use
- low dosage
- dosage
- Prior art date
Links
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 title 1
- 229960005280 isotretinoin Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2827DE2014 | 2014-10-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA40781A true MA40781A (fr) | 2017-08-08 |
Family
ID=55629490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA040781A MA40781A (fr) | 2014-10-01 | 2015-05-28 | Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20160128962A1 (fr) |
| EP (1) | EP3200877A4 (fr) |
| JP (1) | JP6707532B2 (fr) |
| AU (1) | AU2015326489A1 (fr) |
| BR (1) | BR112017006779A2 (fr) |
| CA (2) | CA3207801A1 (fr) |
| MA (1) | MA40781A (fr) |
| MX (2) | MX2017004312A (fr) |
| RU (1) | RU2707753C2 (fr) |
| WO (1) | WO2016051288A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017521470A (ja) * | 2014-07-31 | 2017-08-03 | サン ファーマシューティカル インダストリーズ リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ． | イソトレチノインの経口医薬組成物 |
| US10517846B2 (en) | 2016-05-26 | 2019-12-31 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions for treating acne |
| WO2018073751A1 (fr) * | 2016-10-17 | 2018-04-26 | Sun Pharmaceutical Industries Limited | Procédé de traitement de l'acné |
| US10716774B1 (en) | 2018-01-05 | 2020-07-21 | Yale Pharmaceuticals LLC | Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability |
| TW202320776A (zh) * | 2021-11-04 | 2023-06-01 | 日商興和股份有限公司 | 膠囊劑 |
| WO2023080189A1 (fr) * | 2021-11-04 | 2023-05-11 | 興和株式会社 | Produit médicamenteux |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20001227A1 (es) * | 1998-10-30 | 2000-11-06 | Hoffmann La Roche | Procesos para producir una composicion de isotretinoina |
| US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| FR2807662A1 (fr) * | 2000-04-12 | 2001-10-19 | Cll Pharma | Procede pour stabiliser la granulometrie d'un principe actif verulent disperse dans un liquide et ses applications |
| AU2001289438A1 (en) * | 2000-09-22 | 2002-04-02 | Galephar M/F | Pharmaceutical semi-solid composition of isotretinoin |
| US20050129773A1 (en) * | 2001-12-06 | 2005-06-16 | Inderdeep Bhatia | Isotretinoin nanoparticulate compositions |
| WO2012053013A2 (fr) * | 2010-10-21 | 2012-04-26 | Cadila Healthcare Limited | Compositions pharmaceutiques d'agents anti-acné |
| EP2667842A1 (fr) * | 2011-01-24 | 2013-12-04 | Anterios, Inc. | Compositions de tensio-actifs |
| US9078925B2 (en) * | 2012-06-18 | 2015-07-14 | Galephar Pharmaceutical Research, Inc. | Pharmaceutical semi-solid composition of isotretinoin |
| WO2016189481A1 (fr) * | 2015-05-25 | 2016-12-01 | Sun Pharmaceutical Industries Limited | Composition pharmaceutique orale à dosage quotidien unique |
-
2015
- 2015-05-28 MA MA040781A patent/MA40781A/fr unknown
- 2015-05-29 EP EP15845766.3A patent/EP3200877A4/fr not_active Withdrawn
- 2015-05-29 CA CA3207801A patent/CA3207801A1/fr active Pending
- 2015-05-29 CA CA2963206A patent/CA2963206C/fr active Active
- 2015-05-29 RU RU2017114924A patent/RU2707753C2/ru active
- 2015-05-29 JP JP2017517643A patent/JP6707532B2/ja active Active
- 2015-05-29 MX MX2017004312A patent/MX2017004312A/es active IP Right Grant
- 2015-05-29 AU AU2015326489A patent/AU2015326489A1/en not_active Abandoned
- 2015-05-29 BR BR112017006779-0A patent/BR112017006779A2/pt not_active Application Discontinuation
- 2015-05-29 WO PCT/IB2015/054080 patent/WO2016051288A1/fr active Application Filing
- 2015-12-03 US US14/958,467 patent/US20160128962A1/en not_active Abandoned
-
2017
- 2017-03-31 MX MX2020009444A patent/MX2020009444A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6707532B2 (ja) | 2020-06-10 |
| JP2017530149A (ja) | 2017-10-12 |
| RU2017114924A (ru) | 2018-11-02 |
| US20160128962A1 (en) | 2016-05-12 |
| CA3207801A1 (fr) | 2016-04-07 |
| RU2017114924A3 (fr) | 2019-01-16 |
| RU2707753C2 (ru) | 2019-11-29 |
| EP3200877A1 (fr) | 2017-08-09 |
| BR112017006779A2 (pt) | 2018-01-09 |
| AU2015326489A1 (en) | 2017-04-27 |
| MX2017004312A (es) | 2017-07-07 |
| CA2963206C (fr) | 2023-09-26 |
| WO2016051288A1 (fr) | 2016-04-07 |
| EP3200877A4 (fr) | 2018-05-23 |
| MX2020009444A (es) | 2020-10-08 |
| CA2963206A1 (fr) | 2016-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA52257A (fr) | Compositions pharmaceutiques comprenant blautia et leur administration orale | |
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| DK3116491T3 (da) | Farmaceutiske sammensætninger af terapeutisk aktive forbindelser | |
| MA40781A (fr) | Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale | |
| IL275392B (en) | Agonists compounds, pharmaceutical preparations and methods of using them ppar, | |
| MA54716A (fr) | Réduction de la viscosité de formulations pharmaceutiques | |
| MA46867A (fr) | Formulations pharmaceutiques | |
| DK3709978T3 (da) | Farmaceutisk oral formulering omfattende bakterier | |
| FR3022462B1 (fr) | Composition orale d'anticorps anti-tnfalpha | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| MA43705A (fr) | Formulation pharmaceutique | |
| FR3027521B1 (fr) | Compositions pour administration par voie orale | |
| BR112017013012A2 (pt) | compostos de indenil, composições farmacêuticas e usos médicos destes | |
| MA47516A (fr) | Composition pharmaceutique | |
| EP3148645A4 (fr) | Composition pharmaceutique à base d'isotrétinoïne destinée à la voie orale | |
| MA45158A (fr) | Composition pharmaceutique comprenant de l'éteplirsen | |
| DK3280447T3 (da) | Farmaceutiske formuleringer | |
| EP3302438A4 (fr) | Composition pharmaceutique orale d'isotrétinoïne | |
| DK3601277T3 (da) | Farmaceutisk formulering | |
| EP3148644A4 (fr) | Composition pharmaceutique orale d'isotrétinoïne | |
| DK3453390T3 (da) | Farmaceutisk sammensætning indeholdende polymeriseret lægemiddel | |
| ZA201700843B (en) | Oral pharmaceutical composition of isotretinoin | |
| DK3313370T3 (da) | Oftalmologisk farmaceutisk sammensætning | |
| MA46642A (fr) | Promédicaments d'inhibiteurs de la kallicréine | |
| IT201700038005A1 (it) | Dispositivo per la somministrazione di sostanze |